Variant report

Variant	rs74034350
Chromosome Location	chr14:21095193-21095194
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr14:21080004..21083410-chr14:21093659..21097828,5	MCF-7	breast:
2	chr14:21092315..21096861-chr14:21097694..21101485,4	K562	blood:
3	chr14:21093251..21098332-chr14:21147860..21154024,6	MCF-7	breast:
4	chr14:21093202..21096224-chr14:21149755..21152190,4	MCF-7	breast:
5	chr14:21092294..21096959-chr14:21097631..21101429,5	MCF-7	breast:

Variant related genes	Relation type
ENSG00000258818	Chromatin interaction
ENSG00000214274	Chromatin interaction
ENSG00000259171	Chromatin interaction

Extended variants
information (count: 15 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:10)

rs_ID	r²[population]
rs17113273	1.00[AMR][1000 genomes]
rs56833696	1.00[AMR][1000 genomes]
rs58988374	1.00[AMR][1000 genomes]
rs59800190	1.00[AMR][1000 genomes]
rs61061587	1.00[AMR][1000 genomes]
rs73583394	1.00[AMR][1000 genomes]
rs73585305	1.00[AMR][1000 genomes]
rs73585312	1.00[AMR][1000 genomes]
rs74037153	1.00[AMR][1000 genomes]
rs891298	1.00[AMR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:5 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1043923	chr14:20338742-21336425	Enhancers Strong transcription Weak transcription Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Genic enhancers ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	203 gene(s)	inside rSNPs	diseases
2	nsv541970	chr14:20338742-21336425	Strong transcription Enhancers Flanking Active TSS Weak transcription Genic enhancers Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	203 gene(s)	inside rSNPs	diseases
3	esv21015	chr14:20800765-21257878	Active TSS Flanking Active TSS Enhancers Weak transcription Strong transcription Bivalent/Poised TSS Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	173 gene(s)	inside rSNPs	diseases
4	nsv901468	chr14:20997221-21149785	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	26 gene(s)	inside rSNPs	diseases
5	nsv1051489	chr14:21026592-21214763	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Strong transcription Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	44 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:81 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr14:21091400-21096400	Weak transcription	Pancreas	Pancrea
2	chr14:21092800-21095600	Bivalent Enhancer	Fetal Brain Male	brain
3	chr14:21093000-21095200	Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
4	chr14:21093000-21095200	Active TSS	Brain Cingulate Gyrus	brain
5	chr14:21093000-21095200	Active TSS	Brain Inferior Temporal Lobe	brain
6	chr14:21093000-21095400	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
7	chr14:21093200-21096000	Enhancers	HepG2	liver
8	chr14:21093400-21095200	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
9	chr14:21093400-21095400	Bivalent Enhancer	Fetal Muscle Leg	muscle
10	chr14:21093600-21095200	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
11	chr14:21093800-21095200	Flanking Active TSS	Brain Hippocampus Middle	brain
12	chr14:21093800-21095200	Enhancers	Spleen	Spleen
13	chr14:21093800-21095400	Bivalent Enhancer	Primary B cells from cord blood	blood
14	chr14:21093800-21095800	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
15	chr14:21094000-21095200	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
16	chr14:21094000-21095200	Bivalent Enhancer	Fetal Muscle Trunk	muscle
17	chr14:21094000-21095800	Weak transcription	NHEK	skin
18	chr14:21094000-21096000	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
19	chr14:21094200-21095200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
20	chr14:21094200-21095200	Bivalent Enhancer	Primary hematopoietic stem cells short term culture	blood
21	chr14:21094200-21095200	Bivalent/Poised TSS	Ganglion Eminence derived primary cultured neurospheres	brain
22	chr14:21094200-21095200	Bivalent/Poised TSS	Brain Germinal Matrix	brain
23	chr14:21094200-21095800	Weak transcription	HMEC	breast
24	chr14:21094200-21096000	Weak transcription	Primary T helper naive cells from peripheral blood	blood
25	chr14:21094200-21098600	Weak transcription	Aorta	Aorta
26	chr14:21094400-21095200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
27	chr14:21094400-21095200	Enhancers	Breast Myoepithelial Primary Cells	Breast
28	chr14:21094400-21095200	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
29	chr14:21094400-21095200	Bivalent/Poised TSS	Brain Dorsolateral Prefrontal Cortex	brain
30	chr14:21094400-21095400	Bivalent/Poised TSS	H1 Cell Line	embryonic stem cell
31	chr14:21094400-21095400	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
32	chr14:21094400-21095400	Enhancers	Primary T helper cells fromperipheralblood	blood
33	chr14:21094400-21095400	Bivalent Enhancer	Fetal Intestine Small	intestine
34	chr14:21094400-21095800	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
35	chr14:21094400-21095800	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
36	chr14:21094400-21095800	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
37	chr14:21094600-21095400	Bivalent/Poised TSS	ES-WA7 Cell Line	embryonic stem cell
38	chr14:21094600-21095400	Enhancers	Primary B cells from peripheral blood	blood
39	chr14:21094600-21095400	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
40	chr14:21094600-21095800	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
41	chr14:21094600-21095800	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
42	chr14:21094600-21095800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
43	chr14:21094800-21095200	Active TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
44	chr14:21094800-21095200	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
45	chr14:21094800-21095200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
46	chr14:21094800-21095200	Bivalent Enhancer	Primary hematopoietic stem cells	blood
47	chr14:21094800-21095200	Enhancers	Placenta	Placenta
48	chr14:21094800-21095200	Enhancers	Right Atrium	heart
49	chr14:21094800-21095200	Enhancers	NHDF-Ad	bronchial
50	chr14:21094800-21095400	Bivalent/Poised TSS	iPS DF 19.11 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links